Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor suppressors govern insulin-like growth factor signaling pathways: implications in metabolism and cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 22, Pages 2703-2714
Publisher
Springer Nature
Online
2011-10-03
DOI
10.1038/onc.2011.447
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IGF1R mutations as cause of SGA
- (2011) J. Klammt et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Insulin receptor and cancer
- (2011) A. Belfiore et al. ENDOCRINE-RELATED CANCER
- Congenital IGF1 deficiency tends to confer protection against post-natal development of malignancies
- (2011) Rachel Steuerman et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs
- (2011) E L McKinsey et al. ONCOGENE
- Growth Hormone Receptor Deficiency Is Associated with a Major Reduction in Pro-Aging Signaling, Cancer, and Diabetes in Humans
- (2011) J. Guevara-Aguirre et al. Science Translational Medicine
- MicroRNAs as therapeutic targets in cancer
- (2011) S. Patrick Nana-Sinkam et al. Translational Research
- The insulin-like growth factor-I receptor as an oncogene
- (2011) Haim Werner et al. ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY
- MicroRNA-7 targets IGF1R (insulin-like growth factor 1 receptor) in tongue squamous cell carcinoma cells
- (2010) Lu Jiang et al. BIOCHEMICAL JOURNAL
- Basic and clinical significance of IGF-I-induced signatures in cancer
- (2010) Haim Werner et al. BMC Medicine
- New plays in the p53 theater
- (2010) Yael Aylon et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Targeting insulin-like growth factor 1 receptor in sarcomas
- (2010) Katia Scotlandi et al. CURRENT OPINION IN ONCOLOGY
- 40p53 controls the switch from pluripotency to differentiation by regulating IGF signaling in ESCs
- (2010) E. Ungewitter et al. GENES & DEVELOPMENT
- A Heterozygous Mutation of the Insulin-Like Growth Factor-I Receptor Causes Retention of the Nascent Protein in the Endoplasmic Reticulum and Results in Intrauterine and Postnatal Growth Retardation
- (2010) Tillmann Wallborn et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Heterozygous Mutation within a Kinase-Conserved Motif of the Insulin-Like Growth Factor I Receptor Causes Intrauterine and Postnatal Growth Retardation
- (2010) Tassilo Kruis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
- (2010) Robert G. Maki JOURNAL OF CLINICAL ONCOLOGY
- Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cells
- (2010) Hagit Schayek et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Serum microRNAs as non-invasive biomarkers for cancer
- (2010) Jan C Brase et al. Molecular Cancer
- BRCA mutations in the management of breast cancer: the state of the art
- (2010) Steven A. Narod Nature Reviews Clinical Oncology
- Apoptosis promotes early tumorigenesis
- (2010) D Tang et al. ONCOGENE
- Identification of Insulin-Like Growth Factor-I Receptor (IGF-IR) Gene Promoter-Binding Proteins in Estrogen Receptor (ER)-Positive and ER-Depleted Breast Cancer Cells
- (2010) Rive Sarfstein et al. Cancers
- Targeting the IGF1 axis in cancer proliferation
- (2009) Ilan Bruchim et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Transcription factor E2F1 is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene
- (2009) Hagit Schayek et al. GROWTH HORMONE & IGF RESEARCH
- Novel insights into the role of the tumor suppressor von Hippel Lindau in cellular differentiation, ciliary biology, and cyst repression
- (2009) Michael S. Wiesener et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Emerging role of insulin-like growth factor receptor inhibitors in oncology: early clinical trial results and future directions
- (2009) A Gualberto et al. ONCOGENE
- Nutrition, metabolic factors and cancer risk
- (2008) Laure Dossus et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
- (2008) J. H. Law et al. CANCER RESEARCH
- Insulin-Like Growth Factor-I Regulates Krüppel-Like Factor-6 Gene Expression in a p53-Dependent Manner
- (2008) Itay Bentov et al. ENDOCRINOLOGY
- Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer
- (2008) John SP Yuen et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- IGF and Insulin Receptor Signaling in Breast Cancer
- (2008) Antonino Belfiore et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- IGF signaling defects as causes of growth failure and IUGR
- (2008) Jürgen Klammt et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started